Cerebellar granule cells (CGCs) express the CBI subtype of cannabinoid rece
ptor, CB1 receptor agonists Win 55212-2, CP55940 and HU210 inhibit KCl-indu
ced activation of nitric oxide synthase (NOS) in CGCs, Win 55212-2 has no e
ffect on either basal NOS activity or on activation by N-methyl-D-aspartate
and its effect is abolished by pre-treatment of the cells with pertussis t
oxin. The CB1 receptor antagonist/inverse agonist SR141716A both reverses t
he effects of Win 55212-2 and produces an increase in NOS activity that is
additive with KCI, These results support the hypothesis that activation of
the CB1 receptor in CGCs results in a decreased influx of calcium in respon
se to membrane depolarization, resulting in a decreased activation of neuro
nal NOS. (C) 1999 Federation of European Biochemical Societies.